Yüksel DERELİ, Özgür ALTINBAŞ, Erdal EGE, Omer TANYELİ

Predictive value of platelet to lymphocyte ratio and mean platelet volume in atrial fibrillation after isolated coronary artery bypass graft operation

Aim: The relationship between inflammation and the development of atrial fibrillation and the relationship between platelet tolymphocyte ratio and mean platelet volume in relation to inflammation were investigated in patients with atrial fibrillation afterisolated coronary artery bypass graft operation.Material And Methods: Clinical and laboratory data of 132 patients, who did not have preoperative atrial fibrillation and underwentisolated coronary artery bypass graft operation using cardiopulmonary pump, were analyzed retrospectively. Patients were dividedinto two groups as patients with developed atrial fibrillation and those without atrial fibrillation. Concomitant diseases, preoperativedrug use, echocardiographic and angiographic findings, preoperative, intraoperative and postoperative laboratory parameters wereobtained from medical records and compared statistically.Results: Of the 132 patients, 68 with atrial fibrillation (mean age: 68.3+/-10.7 years, 50 males and 18 females) and 64 patientswithout atrial fibrillation (mean age: 64.5+/-9.8 years, 55 males and 9 females) were identified, and difference in the mean agewas statistically significant (p=0.016). Postoperative platelet to lymphocyte ratio and mean platelet volume values (280.3+/-112.3;9.9+/-1.7) were also significantly higher in those with atrial fibrillation group than preoperative values (129.2+/-49.3; 9.6+/-1.6,p

PDF

___

1. Takeshi O, Yuichi K. Management of postoperative atrial fibrillation. J Anesth 2012;26:429-37.
2. Yutao G, Gregory YH, Stavros A. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263-70.
3. Akboga MK, Canpolat U, Yayla C, et al. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology 2016;67:89-95.
4. Xue-Feng X, Feng-Lin J, Mei-Jun O, et al. The association between mean platelet volume and chronic atrial fibrillation and the presence of thrombotic events. Biomed Rep 2015;3:388-94.
5. Gungor H, Eryılmaz U, Akgullu C, et al. Preoperative poor coronary collateral circultion can predict the development of atrial fibrillation after coronary artery bypass graft surgery. Coronary Artery Disease 2013;24:572-6.
6. Gungor H, Ayik MF, Kirilmaz B, et al. Serum resistin level: as a predictor of atrial fibrillation after coronary artery bypass graft surgery.Coronary Artery Disease 2011;22:484-90.
7. Rienstra M, McManus DD, Benjamin EJ. Novel risk factors for atrial fibrillation.Circulation 2012;125:941-6.
8. Zangrillo A, Landoni G, Sparicio D et al. Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery.J Cardiothorac Vasc Anesth 2004;18:704-8.
9. Benjamin E.J, Wolf P.A, D’Agostino R.B et al. Impact of atrial fibrillation on the risk of death:the Framingham heart study. Circulation 1998;98:946-52.
10. Çiçekçioğlu F, Kervan Ü, Parlar Aİ, et al. Koroner bypass cerrahisinden sonra gelişen atriyal fibrilasyon tedavisinde amiodaronun etkinliği. Türk Kalp Damar Cerrahi Derg 2009;17:077-82.
11. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4.
12. Gibson PH, Cuthbertson BH, Croal BL et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
13. Abdelhadi RH, Gurm HS, Wagoner DR, et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004;93:1176-8.
14. Aviles RJ, Martin DO, Apperson HC, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006- 10.
15. Lo B, Fijnheer R, Nierich AP, et al. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005;79:1530-5.
16. Paparella D, Yau T M, Young E. Cardiopulmaonary bypass induced inflammation:pathophysiology and treatment.An update. Eur J Cardiothorac Surg 2002;21:232-44.
17. Sari I, Sunbul M, Mammadov C, et al. Relation of neutrophilto- lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography. Kardiol Pol 2015;73:1310-6.
18. Varim C, Varim P, Acar BA, et al. Usefulness of the plateletto- lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography. Kao J of Med Scis 2016;32:86-90.
19. Altintas Ö, Tasal A, Niftaliyev E, et al. Association of plateletto- lymphocyte ratio with silent brain infarcts in patients with paroxysmal atrial fibrillation. A J Progress in Neurosurgery, Neurology and Neurosciences 2016;38:753-8.
20. Akboga MK, Canpolat U, Balci KG et al. Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology 2016;67:21-6.
21. Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and longterm major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology 2016;67:336-45.
22. Azab B, Shah N, Akerman M, et al. Value of platelet/ lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326-34.
23. Gary T, Picher M, Belaj K et al. Platelet-to-lymphocyte ratio:a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLos One 2013;8:e67688.
24. Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol 2015;15:640-7.
25. Ignacio MS, Francisco JR, Rodolfo P, et al. Neutrophilto- lymphocyte ratio and platelet-tolymphocyte ratio as predictors of survival after heart transplantation. ESC Heart Failure 2018;5:149-56.
26. Gungor H, Babu AS, Zencir C, et al. Association of preoperative platelet-to-lymphocyte ratio with atrial fibrillation after coronary artery bypass graft surgery. Med Princ Pract 2017;26:164-8.
27. Tekin G, Tekin YK, Sivri N, et al. Mean platelet volume in patients with nonvalvular atrial fibrillation. Blood Coagul Fibrinolysis 2013;24:537-9.
28. Xu X.F, Jiang F.L, Ou M.J, Zhang Z.H. The association between mean platelet volume and chronic atrialfibrillation and the presence of thrombotic events. Biomed Rep 2015;3:388-94.
29. Turfan M, Erdogan E, Ertas G et al. Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients. Blood Coagul Fibrinolysis 2013;24:55-8.
30. Aygün F, Özülkü M, Günday M. Preoperatif MPV,KABGO sonrası serebrovasküler olay için prediktör olabilir mi? Cumhuriyet Tıp Derg 2014;36:540-7.
31. Gunluoglu G, Yazar EE, Veske NS, et al. Mean platelet volume as an inflammtion marker in active pulmonary tuberculosis. Multidiscip Respir Med 2014;28:11.
32. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume:a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.